Bayer investors re-elect Winkeljohann as board chairman
Reuters
Published Apr 28, 2023 09:28
Updated Apr 28, 2023 18:21
FRANKFURT (Reuters) - Bayer (ETR:BAYGN) Chairman Norbert Winkeljohann on Friday comfortably won a re-election vote at the drugmaker's annual shareholder meeting with an approval rate of 79.6%.
Germany's three biggest asset management groups earlier said they would not vote for his renewed term at Bayer because of his numerous other board commitments.
An ouster of Winkeljohann, who won wide investor praise for securing former Roche executive Bill Anderson as Bayer's CEO-designate, would have sparked upheaval at the healthcare and agriculture group, which has attracted activist shareholders and is facing costly litigation.
DWS, Union Investment and Deka Investment, who according to Refinitiv data hold a combined 3.8% in Bayer, had said separately they would not vote for the supervisory board chairman.
Major shareholder advisory firms Glass Lewis and Institutional Shareholder Services (ISS), for their part, have said they would back Winkeljohann.
Singapore's sovereign wealth fund Temasek, a major shareholder in Bayer, would also vote for Winkeljohann, German magazine WirtschaftsWoche reported this month.
Winkeljohann said he had enough time to supervise Bayer.
"I don't see any reason at the moment to reduce my board mandates," he added.
Winkeljohann is also Deutsche Bank (ETR:DBKGn)'s deputy chairman, chairman at unlisted wholesale trade groups Sievert SE and Bohnenkamp AG as well as a board member at steelmaker Georgsmarienhuette GmbH.
The AGM is the last for Bayer CEO Werner Baumann, who steps down in June. He said on Friday that the company was in a very good strategic position, while also acknowledging that its stock market value was too low.
Shareholders delivered an approval vote of only 52% for the company's management remuneration system.
Winkeljohann had earlier pledged to review the scheme over the next 12 months and said the company cannot be satisfied with the thin majority of the vote.
Get The App
Written By: Reuters
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.